Physician
Physical Medicine/Rehab
Dr. Janet E. Freedman, MD
|
|
Give Review
Doctor Janet E. Freedman, MD works in the field of Physical Medicine/Rehab. She went to medical school at University of Wisconsin School of Medicine and Public Health. She has 2 awards "Top Doctors: New York Metro Area" and "Greenwich Magazine". Doctor Janet E. Freedman, MD is also a published doctor. She has 101 paper published. The most recent paper is: Nitric oxide and superoxide detection in human platelets. She accepts Medicare.
Publications
- Cationic agent contrast-enhanced computed tomography imaging of cartilage correlates with the compressive modulus and coefficient of friction.
- Monoclonal antibody-mediated inhibition of the human HLA alloimmune response to platelet transfusion is antigen specific and independent of Fcgamma receptor-mediated i...
- The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children.
- Reticulated platelet counts in the assessment of thrombocytopenic Disorders.
- Random donor platelet crossmatching: comparison of four platelet antibody detection methods.
- Interleukins 1beta, 6, 8 and tumour necrosis factor alpha do not induce platelet activation.
- Antibody-mediated inhibition of the human alloimmune response to platelet transfusion in Hu-PBL-SCID mice.
- Natural killer cell numbers and activity in patients with Chronic autoimmune thrombocytopenic purpura.
- Distribution of TRH-like immunoreactivity with special reference to coexistence with other neuroactive compounds.
- Platelet activation induced by porcine factor VIII (Hyate:C).
- Prospective platelet crossmatching for selection of compatible random donors.
- Flow cytometric analysis of platelet function in stored platelet concentrates.
- Quantification of platelet activation status by analyzing P-selectin expression.
- Abnormal cellular immune mechanisms associated with autoimmune thrombocytopenia.
- Platelet-surface glycoproteins in healthy and preeclamptic mothers and their newborn infants.
- Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant.
- Higher thrombin concentrations are required to induce platelet apoptosis than to induce platelet activation.
- Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity.
- Thrombin-triggered platelet apoptosis.
- Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits.
- Antioxidant versus lipid-altering therapy--some answers, more questions.
- Platelet cold agglutinins: a flow cytometric analysis.
- Concurrent measurement of the survival of two populations of rabbit platelets labeled with either two PKH lipophilic dyes or two concentrations of biotin.
- Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo.
- Comparison of platelet immunity in patients with SLE and with ITP.
- Indirect platelet radioactive antiglobulin test in patients with lymphoproliferative Disease.
- Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura.
- Inhibition of a secondary human alloimmune response via the soluble active component of CD154 (CD40L) in severe combined immune-deficient mice engrafted with human lym...
- Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62) expression: theoretical consideration and evaluation in thrombin-treat...
- Thrombin binding to platelets and their activation in plasma.
- Flow cytometric evaluation of platelet activation in blood collected into EDTA vs. Diatube-H, a sodium citrate solution supplemented with theophylline, adenosine, and ...
- Plasmin accelerates platelet-dependent prothrombinase formation without activating the platelets.
- Platelet activation in warm and cold heart surgery.
- p38 MAPK is activated but not necessary in porcine von Willebrand factor-dependent platelet activation.
- Flow cytometric analysis of platelets from children with the Wiskott-Aldrich Syndrome reveals defects in platelet development, activation and structure.
- Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation.
- Platelet activation and von Willebrand factor binding to platelets in newborn infants with central venous lines.
- Platelet activation and hypercoagulability following treatment with porcine factor VIII (HYATE:C).
- Binding of thrombin to the G-protein-linked receptor, and not to glycoprotein Ib, precedes thrombin-mediated platelet activation.
- Differences in serum cytokine levels in acute and Chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity.
- Downregulation of the anti-HLA alloimmune response by variable region-reactive (anti-idiotypic) antibodies in leukemic patients transfused with platelet concentrates.
- von Willebrand factor (VWF)-dependent human platelet activation: porcine VWF utilizes different transmembrane signaling pathways than does thrombin to activate platele...
- Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens.
- Thrombin, thrombomodulin, and extracellular signal-regulated kinases regulating cellular proliferation.
- Porcine von Willebrand factor and thrombin induce the activation of c-Jun amino-terminal kinase (JNK/SAPK) whereas only thrombin induces activation of extracellular si...
- Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia.
- Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity.
- Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lym...
- Purification and characterization of human platelet glutathione-S-transferase.
- Unsaturated fatty acids enhance low density lipoprotein uptake and degradation by Peripheral blood mononuclear cells.
- Abciximab pharmacodynamic model with neural networks used to integrate sources of patient variability.
- Kinetics and mechanism of platelet-surface plasminogen activation by tissue-type plasminogen activator.
- Nitric oxide and its relationship to thrombotic Disorders.
- Endothelial dysfunction and atherothrombotic occlusive Disease.
- Recipient humoral immunity against leukoreduced allogeneic platelets is suppressed by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase.
- Impaired EDRF production by endothelial cells exposed to fibrin monomer and FDP.
- O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin.
- Vitamin E inhibition of platelet aggregation is independent of antioxidant activity.
- Nitric oxide and superoxide detection in human platelets.
- A new role for the A2b adenosine receptor in regulating platelet function.
- alpha-Tocopherol and protein kinase C inhibition enhance platelet-derived nitric oxide release.
- Soluble adhesion molecules and unstable coronary artery Disease.
- A statement on ethics from the HEART Group.
- Vitamin E and vascular homeostasis: implications for atherosclerosis.
- Nitric oxide insufficiency and arterial thrombosis.
- Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols.
- Pharmacological control of platelet function.
- Heparin reacts with and inactivates nitric oxide.
- Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase.
- NFkappaB regulation of platelet function: no nucleus, no genes, no problem?
- Pharmacodynamics of abciximab during angioplasty: comparison to healthy subjects.
- Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke.
- Pharmacodynamic profile of short-term readministration of abciximab in healthy subjects.
- Platelets and plasminogen activation.
- Nitric oxide released from activated platelets inhibits platelet recruitment.
- Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis.
- Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue.
- Low plasma ascorbic acid independently predicts the presence of an unstable coronary Syndrome.
- alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism.
- High-dose heparin decreases nitric oxide production by cultured bovine endothelial cells.
- S-Transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide.
- Impaired platelet production of nitric oxide predicts presence of acute coronary Syndromes.
- Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release.
- Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene.
- A platelet transcriptome revolution.
- Inflammation & the platelet histone trap.
- Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity.
- Regulatory effects of TLR2 on megakaryocytic cell function.
- Relationship Between Markers of Platelet Activation and Inflammation with Disease Activity in Wegener's Granulomatosis.
- [Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments].
- The role of the blood transcriptome in innate inflammation and stroke.
- Use of genetics and transcriptomics in the diagnosis and treatment of coronary artery Disease.
- Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study.
- Review: Nutriceuticals as antithrombotic agents.
- The role of CD40L and VEGF in the modulation of angiogenesis and inflammation.
- p38: signaling improved platelet storage?
- Blood and cardiovascular Disease: the promise and limitations of gene expression analysis.
- The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes.
- New therapies for stroke prevention in atrial fibrillation: the long road to enhanced efficacy.
- Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release.
Schools
University of Wisconsin Madison
New York University Med Center
Rusk Institute Rehab Med
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Non-Cosmetic Chemodenervation
- Trigger Point Injection
Conditions Treated
- Achilles Tendinitis
- Adhesive Capsulitis
- Ankle Sprain and Achilles Tendon Sprain or Rupture
- Arthritis
- View All
Doctors Specialties
- Physical Medicine/Rehab
Accepted Insurances
Awards
- Top Doctors: New York Metro Area
- Greenwich Magazine
Education
-
University of Wisconsin School of Medicine and Public Health
Hospital
-
Greenwich Hospital
Drug Facts
| NPI NUMBER | 1326062233 | |
| NPPES Provider LastName | FREEDMAN | |
| NPPES Provider FirstName | JANET | |
| NPPES Provider ZIPCode | 068304608 | |
| NPPES Provider State | CT | |
| Specialty Description | Physical Medicine and Rehabilitation | |
| Total Claim Count | 61.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326062233 |
| Last Name Of The Provider | FREEDMAN |
| First Name Of The Provider | JANET |
| View All |
Similar Doctors
|
Dr. Jeffrey M. Heftler, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jun Xu, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Tamar Kessel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James B. Fesko, MD
This Doctor is OpenDoctor Recommended.
|